Cortagen (20 mg Vial) Dosage Protocol

Plan based on a 4-week daily protocol with gradual titration (1000–2000 mcg/day).

• Peptide Vials (Cortagen, 20 mg each):
  • 4 weeks ≈ 3 vials (at average 1500 mcg/day = 42 mg total)
  • 8 weeks ≈ 5 vials
• Insulin Syringes (U-100):
  • Per week: 7 syringes (1/day)
  • 4 weeks: 28 syringes
  • 8 weeks: 56 syringes
• Bacteriostatic Water (10 mL bottles): Use 3.0 mL per vial for reconstitution.
  • 4 weeks (3 vials): 9 mL → 1 × 10 mL bottle
  • 8 weeks (5 vials): 15 mL → 2 × 10 mL bottles
• Alcohol Swabs: One for the vial stopper + one for the injection site each day.
  • Per week: 14 swabs (2/day)
  • 4 weeks: 56 swabs → recommend 1 × 100-count box
  • 8 weeks: 112 swabs → recommend 2 × 100-count boxes

Cortagen 20 mg

View Supplier

U-100 syringes

View Supplier

Bacteriostatic water

View Supplier

Alcohol swabs

View Supplier

Practice preparing this vial with the verified strength and final volume from this protocol.

• Reconstitute: Add 3.0 mL bacteriostatic water → 6.67 mg/mL (6670 mcg/mL) concentration.
• Typical daily range: 1000–2000 mcg once daily (morning administration preferred).
• Easy measuring: At 6.67 mg/mL, 1 unit = 0.01 mL ≈ 66.7 mcg on a U-100 insulin syringe.
• Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles.

Cortagen dosage protocols are designed around this synthetic tetrapeptide (Ala-Glu-Asp-Pro) that belongs to the Khavinson bioregulator class, studied for its neuroprotective and neuroregenerative properties^[1][2]. Research indicates Cortagen may support peripheral nerve regeneration, enhance cognitive function, reduce oxidative stress in neural tissues, and promote cellular repair mechanisms without significant adverse effects at therapeutic doses^[3][4]. This educational protocol presents a once-daily subcutaneous approach using a practical dilution for clear insulin-syringe measurements.

Concise summary of the once-daily regimen.

• Goal: Support neural regeneration, cognitive function, and cellular repair mechanisms over time^[1][3].
• Schedule: Daily subcutaneous injections for 4 weeks (extend to 8 weeks if desired).
• Dose Range: 1000–2000 mcg daily with optional gradual titration.
• Reconstitution: 3.0 mL per 20 mg vial (6.67 mg/mL) for accurate unit measurements.
• Storage: Lyophilized frozen; reconstituted refrigerated; avoid repeated freeze–thaw.

Suggested daily dosing approach based on research.

• Start: 1000 mcg (1 mg) daily for Weeks 1–2.
• Target: 2000 mcg (2 mg) daily for Weeks 3–4.
• Frequency: Once per day (subcutaneous).
• Cycle Length: 4 weeks standard; optional extension to 8 weeks.
• Timing: Morning administration preferred; rotate injection sites.

Proper storage preserves peptide quality.

• Lyophilized: Follow the exact product’s labeled storage temperature and expiration date; do not infer a shelf life from refrigeration or freezing alone.
• Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); follow product-specific use-by instructions and avoid freeze–thaw.
• Allow vials to reach room temperature before opening to reduce condensation uptake.

Practical considerations for consistency and safety.

• Use new sterile insulin syringes; dispose in a sharps container.
• Rotate injection sites (abdomen, thighs, upper arms) to reduce local irritation^[8].
• Inject slowly; wait a few seconds before withdrawing the needle.
• Document daily dose and site rotation to maintain consistency.

Cortagen (Ala-Glu-Asp-Pro) is a synthetic tetrapeptide derived from amino acid analysis of the natural brain cortex preparation Cortexin^[3]. It acts as a gene expression modulator and epigenetic regulator, influencing the synthesis of proteins involved in neuronal growth, differentiation, and stress resistance^[6][7]. Preclinical studies demonstrate that Cortagen can upregulate neurotrophic factors, reduce oxidative stress markers, and accelerate peripheral nerve regeneration - increasing nerve fiber growth rate and conduction velocity by 27–40% in injury models^[1]. In chronic cerebral ischemia models, Cortagen improved behavioral recovery and protected against oxidative damage^[2].

Observations from preclinical and limited clinical literature.

• Supports peripheral nerve regeneration with improved growth rate and conduction velocity in injury models^[1].
• Demonstrates neuroprotective effects in ischemia models by reducing lipid peroxidation and preserving antioxidant enzyme activity^[2].
• May enhance cognitive function and memory through promotion of synaptic plasticity and neurite outgrowth^[4][5].
• Shows gene expression modulation in cardiac and neural tissues with broad regulatory effects^[3][6].
• Generally well tolerated with no significant adverse effects observed at therapeutic doses in animal studies^[5].
• Occasional mild injection-site reactions (redness/itch) may occur with subcutaneous administration.

Complementary strategies for optimal outcomes.

• Maintain a nutrient-rich diet with adequate protein, omega-3 fatty acids, and antioxidants to support neural health.
• Engage in regular physical activity and cognitive exercises to reinforce neuroplasticity.
• Prioritize quality sleep and stress management to support cellular repair and recovery.

General subcutaneous guidance from clinical best-practice resources^[8][9].

• Clean the vial stopper and skin with alcohol; allow to dry.
• Pinch a skinfold; insert the needle at 45–90° into subcutaneous tissue.
• Do not aspirate for subcutaneous injections; inject slowly and steadily^[9].
• Rotate sites systematically (abdomen, thighs, upper arms) to avoid lipohypertrophy^[8].

This content is for educational purposes only and is not medical advice.

• 1
  
  PubMed
  - Effect of tetrapeptide cortagen on regeneration of sciatic nerve (nerve growth rate and conduction velocity improvements)

  View Source
• 2
  
  PubMed
  - Cortexin and cortagen as correcting agents in functional and metabolic disorders in the brain in chronic ischemia

  View Source
• 3
  
  PubMed (Neuroendocrinology Letters)
  - Elucidation of the effect of brain cortex tetrapeptide Cortagen on gene expression in mouse heart by microarray

  View Source
• 4
  
  PubMed (Biogerontology)
  - Peptide bioregulation of aging: results and prospects (lifespan extension and biomarker modulation)

  View Source
• 5
  
  Bentham Open (Open Neuropsychopharmacology Journal)
  - Modulatory effects of Cortexin and Cortagen on locomotor activity and anxiety-related behavior in mice

  View Source
• 6
  
  MDPI (Molecules)
  - Peptide Regulation of Gene Expression: A Systematic Review (epigenetic mechanisms)

  View Source
• 7
  
  Springer (Bulletin of Experimental Biology and Medicine)
  - Mechanisms Underlying Geroprotective Effects of Peptides

  View Source
• 8
  
  MedlinePlus
  - Subcutaneous (SQ) injections: technique, site rotation, and best practices

  View Source
• 9
  
  CDC (Subcut Injection PDF)
  - Vaccine Administration: Subcutaneous (SUBCUT) Injection technique and guidance

  View Source
• 13
  
  Pure Lab Peptides
  - Cortagen (20 mg) product page (quality and batch documentation)

  View Source

Additional Research and Background

These sources provide related context and are not presented as support for a specific statement above.

• 1
  
  MDPI (International Journal of Molecular Sciences)
  - Short Peptides Protect Fibroblast-Derived Induced Neurons from Age-Related Changes

  View Source
• 2
  
  Wikipedia
  - Cortagen (tetrapeptide overview and background)

  View Source

Explore the available research context, protocol variants or comparisons, and practical guides. When vial-size variants exist, they remain separate because vial strength, concentration, and syringe-unit calculations can differ. Related compounds and blends are comparisons only, not interchangeable.